HbOT may be a valuable additional therapy for cancer patients undergoing chemotherapy or radiation therapy.
Summary
- Hyperbaric oxygen therapy (HBOT) is a therapy in which patients breathe pure oxygen in a pressurised chamber. It helps with infection, wound healing, and radiation damage.
- In 2021, HBOT was found to boost survival rates and reduce tumour development in mice with breast cancer. It also made the cancer cells more vulnerable to radiation therapy.
- The study suggests that HBOT may be a valuable adjunct therapy for cancer patients undergoing chemotherapy or radiation therapy.
- HBOT may be a promising therapy for cancer patients, but it should not be used as a standalone treatment.
- The research shows that HBOT can help cancer patients by lowering tumour development, increasing survival rates, improving the way chemotherapy medications are delivered, and boosting their immune systems.
- We do not recommend Hyperbaric oxygen Therapy as a replacement for conventional treatments, if you are unsure please consult your doctor.
Can HbOT help cancer patients?
Hyperbaric oxygen therapy (HbOT) is a therapy in which patients breathe pure oxygen in a pressurised chamber. The higher pressure aids in the blood’s ability to carry oxygen to the body’s tissues and organs. Many medical diseases, including infections, wound healing, and radiation damage, have all been treated using HBOT. Recent studies have also revealed that HBOT may enhance the efficacy of radiation and chemotherapy for cancer patients.
A 2021 research article that appeared in the journal Scientific Reports examined HBOT as a potential therapy for cancer in mice. HBOT was found to greatly boost survival rates and considerably reduce tumour development in mice with breast cancer. The study also discovered that HBOT has the power to raise the oxygen levels in the tumour microenvironment. Chemotherapy medications were able to penetrate tumour cells more efficiently as a consequence. The cancer cells also become more vulnerable to radiation therapy as a result of raising the body’s oxygen level.
The study suggests that HBOT may be a valuable additional therapy for cancer patients undergoing chemotherapy or radiation therapy. By improving oxygenation in the tumour microenvironment, HBOT can enhance the effectiveness of these treatments. This can potentially reduce the need for more invasive interventions, such as surgery. Additionally, HBOT has minimal side effects and can safely be used in conjunction with other cancer treatments.
According to the study, HBOT may be an effective supplemental treatment for cancer patients receiving chemo or radiation. HBOT can increase the efficiency of these therapies by increasing oxygenation in the tumour microenvironment. This could lessen the need for more intrusive treatments like surgery. Moreover, HBOT is safe to use in combination with other cancer therapies and has few adverse effects.
While more research is needed to fully understand the benefits of HBOT for cancer patients, the existing evidence suggests that it may be a promising therapy. However, it is important to note that HBOT should not be used as a standalone treatment for cancer. Rather, it should be used in conjunction with other cancer therapies to enhance their effectiveness.
In conclusion, the research reported in Scientific Reports shows that HBOT can help cancer patients by lowering tumour development, increasing survival rates, improving the way chemotherapy medications are delivered, and boosting their immune systems. The mild adverse effects of HBOT make it safe to combine it with other cancer therapies. To fully comprehend the potential advantages of HBOT and to determine how best to employ it in cancer therapy, more investigation is nonetheless required.
